Why and How We Should Treat Elderly Patients with Hypertension?

Author(s): Wilbert S. Aronow.

Journal Name: Current Vascular Pharmacology

Volume 8 , Issue 6 , 2010

Submit Manuscript
Submit Proposal

Abstract:

Double-blind, randomized, placebo-controlled studies have documented that antihypertensive drug therapy decreases cardiovascular events in older persons. In the Hypertension in the Very Elderly Trial, patients aged 80 years and older treated with antihypertensive drug therapy had at 1.8-year follow-up, a 30% insignificant decrease in fatal or nonfatal stroke, a 39% significant decrease in fatal stroke, a 21% significant decrease in all-cause mortality, a 23% insignificant decrease in death from cardiovascular causes, and a 64% significant decrease in heart failure. The goal of treatment of hypertension in older persons is to decrease the blood pressure to < 140/90 mm Hg and to < 130/80 mm Hg in older persons with diabetes or chronic renal disease. Elderly persons with diastolic hypertension should have their diastolic blood pressure reduced to 80 to 85 mm Hg. There are no randomized controlled clinical trials supporting a target blood pressure of less than 130/80 mm Hg in elderly persons. The optimum diastolic blood pressure goal in elderly persons is unclear. Diuretics should be used as initial therapy in persons with no associated medical conditions. The selection of antihypertensive drug therapy in persons with associated medical conditions depends on their medical conditions. If the blood pressure is > 20/10 mm Hg above the goal blood pressure, drug therapy should be initiated with 2 antihypertensive drugs. Other coronary risk factors must be treated.

Keywords: Hypertension, elderly, antihypertensive drug therapy, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, diabetes, chronic renal disease, diastolic blood pressure, drug therapy, systolic blood pressure, Pseudohypertension, Osler maneuver, nterstitial fibrosis, calcification, catecholamines, postprandial hypotension, Framingham Heart study, stroke, left ventricular hypertrophy, heart failure, cardiovascular mortality, renal insufficiency, Hypertension in the Very Elderly Trial, Perindopril, National Com-mittee on Detection, Evaluation, and Treatment of Hyperten-sion, orthostatic hypotension, thiazide-type diuretic, hyponatremia, hypomagnesemia, renal artery stenosis, polycystic kidney disease, sepsis, cyclosporine, sinus bradycardia, sinoatrial disease, atrioventricular block, bronchospasm, clonidine, reserpine, guanethidine, tachycardia, angina pectoris

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 8
ISSUE: 6
Year: 2010
Page: [780 - 787]
Pages: 8
DOI: 10.2174/157016110793563933
Price: $58

Article Metrics

PDF: 4